期刊文献+

肿瘤化疗辅助药物研究进展 被引量:11

Progresses in the study of chemotherapy protectants
下载PDF
导出
摘要 本文对 5 -羟色胺 3受体拮抗剂、集落刺激因子、双磷酸盐、氨磷汀以及白细胞介素 - 11等化疗辅助药物的研究进展作一综述。
作者 董梅 冯奉仪
出处 《国外医学(肿瘤学分册)》 2002年第1期21-25,共5页 Foreign Medical Sciences (Cancer Section)
  • 相关文献

参考文献16

  • 1Perez EA, Lembersky B, Kaywin P, et al. Intravenous(IV) granisetron vs ondansetron in the prevention of cyclophosphamide-doxorubicin-induced emesis in breast cancer patients: a double blind crossover study[J]. Proc Am Soc Clin Oncol, 1996, 15: 543.
  • 2Perez EA, Hesketh P, Sandbach J, et al. Comparison of single dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetngenic chemotherapy: a multicenter, double-blind, randimized parallel study[J]. J Clin Oncol, 1998, 16(2): 754-760.
  • 3Navari R, Gandara D,Hesketh P,et al. Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin induced emesis[J]. J Clin Oncol, 1995, 13(5): 1242-1248.
  • 4Gralla RJ, Navari RM, Hesketh PJ, et al. Single-dose oral granisetron, has equivalent antiernetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based ehernotherapy[J]. J Clin Oncol, 1998, 16(4): 1568-1573.
  • 5Anonymous. Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy[J]. N Engl J Med, 2000, 342(21): 1554-1559.
  • 6Crawford J, Ozer H, Stoller R, et al. Reduction by granuloeyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer (r-metHuC- CSF) [J]. N Engl J Med, 1991,325(3) : 164-170.
  • 7Maher D, Green M, Bishop J, et al. Randomized, placebo controlled trial of filgrastim (r-metHuG-CSF) in patients with febrile neutropenia (FN)following chemotherapy(CT) [J]. Proc Am Soc Clin Oncol, 1993, 12: 434.
  • 8Trillet Lenoir V, Green J, Manegold C, et al. Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy[J]. Eur J Cancer, 1993, 29A(3): 319-324.
  • 9Gebbia V, Testa A, Valenza R, et al. A prospective evaluation of the activity of human granulocyte-colony stimulating factor on the prevention of chemotherapy-related neutropenia in patients with advanced carcinoma[J]. J Chemother, 1993, 5(3): 186-190.
  • 10Hortobagyi GN, Theriault RL, Porter L, et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases[J]. N Engl J Med, 1996, 335(24): 1785-1791.

同被引文献68

  • 1贾国洪,朱习琴,王珍,尚培中.肿瘤化疗药物及其辅助药物的合理应用[J].中国煤炭工业医学杂志,2004,7(6):488-489. 被引量:1
  • 2姚连昌,杨仁杰.原发性肝癌化疗用药的现状与展望[J].临床肝胆病杂志,2005,21(1):62-64. 被引量:13
  • 3胡夕春,蔡扬,杨新苗,李进.肿瘤化疗用药方法的研究进展[J].世界临床药物,2005,26(11):646-649. 被引量:19
  • 4赫连鸿昌,朱佩茹,刘素华,麻会云.晚期肝癌肝动脉灌注化疗(附43例)[J].现代肿瘤医学,2006,14(10):1306-1306. 被引量:1
  • 5何流 张宏星 等.应用国产特尔立治疗肿瘤化疗所致白细胞减少的疗效观察[J].实用临床医学,1999,13(4):22-24.
  • 6Leung TW,Tang AM,Zee B,et al.Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin,interferon-alpha,doxorubicin and 5-fluorouracil chemotherapy[J].Cancer,2002,94(9):421-427.
  • 7Kanmematsu T.Is postoperative chemotherapy effective for the prevention of recurrence after surgery for hepatocellular carcinoma[J].Hepato Gastroenterol,1996,4(3):1404-1405.
  • 8Poon RT,Ngan H,Lo CM,et al.Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence[J].J Surg Oncol,2000,73(2):109-114.
  • 9Nakashima K,Kinno S,Kim YI,et al.Postoperative adjuvant arterial infusion chemotherapy for patients with hepatocellular carcinoma[J].Hepato-gastrorenterology,1996,43(12):1410-1414.
  • 10TakagiK,Koyama T,Hasegawa M.et al.The effect of hepatic arteiral infusion chemotherapy on the prognosis after heparectomy for hepatocellular carcinoma[J].Gan To Kagaku Rycho.1998,25(4):597.

引证文献11

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部